Want to see GB:OBD full AI Analyst Report?
Total Valuation
Oxford BioDynamics has a market cap or net worth of £4.29M. The enterprise value is 7.45M .
Market Cap£4.29M
Enterprise Value7.45M
Share Statistics
Oxford BioDynamics has 4,290,911,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,290,911,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Oxford BioDynamics’s return on equity (ROE) is -9.99 and return on invested capital (ROIC) is -153.84%.
Return on Equity (ROE)-9.99
Return on Assets (ROA)-1.38
Return on Invested Capital (ROIC)-153.84%
Return on Capital Employed (ROCE)-1.95
Revenue Per Employee21.47K
Profits Per Employee-218.69K
Employee Count51
Asset Turnover0.14
Inventory Turnover37.15
Valuation Ratios
The current PE Ratio of Oxford BioDynamics is ―. Oxford BioDynamics’s PEG ratio is 0.00721.
PE Ratio―
PS Ratio6.02
PB Ratio5.90
Price to Fair Value5.90
Price to FCF-0.85
Price to Operating Cash Flow-0.52
PEG Ratio0.00721
Income Statement
In the last 12 months, Oxford BioDynamics had revenue of 1.09M and earned -11.15M in profits. Earnings per share was >-0.01.
Revenue1.09M
Gross Profit-6.15M
Operating Income-10.66M
Pretax Income-11.42M
Net Income-11.15M
EBITDA-9.80M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -7.28M and capital expenditures -24.00K, giving a free cash flow of -7.30M billion.
Operating Cash Flow-7.28M
Free Cash Flow-7.30M
Free Cash Flow per Share>-0.01
Dividends & Yields
Oxford BioDynamics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.40
52-Week Price Change-61.54%
50-Day Moving Average0.16
200-Day Moving Average0.26
Relative Strength Index (RSI)34.86
Average Volume (3m)21.87M
Important Dates
Oxford BioDynamics upcoming earnings date is Jan 26, 2027, TBA (Confirmed).
Last Earnings DateJun 30, 2026
Next Earnings DateJan 26, 2027
Ex-Dividend Date―
Financial Position
Oxford BioDynamics as a current ratio of 0.88, with Debt / Equity ratio of 131.61%
Current Ratio0.88
Quick Ratio0.80
Debt to Market Cap0.00
Net Debt to EBITDA-0.38
Interest Coverage Ratio-25.27
Taxes
In the past 12 months, Oxford BioDynamics has paid -269.00K in taxes.
Income Tax-269.00K
Effective Tax Rate0.02
Enterprise Valuation
Oxford BioDynamics EV to EBITDA ratio is -1.05, with an EV/FCF ratio of -1.33.
EV to Sales9.41
EV to EBITDA-1.05
EV to Free Cash Flow-1.33
EV to Operating Cash Flow-1.34
Balance Sheet
Oxford BioDynamics has £2.51M in cash and marketable securities with £4.28M in debt, giving a net cash position of -£1.77M billion.
Cash & Marketable Securities£2.51M
Total Debt£4.28M
Net Cash-£1.77M
Net Cash Per Share>-£0.01
Tangible Book Value Per Share<£0.01
Margins
Gross margin is -277.32%, with operating margin of -973.79%, and net profit margin of -1018.54%.
Gross Margin-277.32%
Operating Margin-973.79%
Pretax Margin-1043.11%
Net Profit Margin-1018.54%
EBITDA Margin-895.07%
EBIT Margin-1004.57%
Analyst Forecast
The average price target for Oxford BioDynamics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast33.37%
EPS Growth Forecast86.41%